Requests from hospital pharmacists to research laboratories of pharmaceutical companies

Masato Yamamoto, Toshitaka Nabeshima

Research output: Contribution to journalReview article

Abstract

It is likely that requests from hospital pharmacists to pharmaceutical companies are increasing with the greater sophistication and diversification of hospital pharmacist's practice in recent years. However, there is no nation-wide information concerning the requests to pharmaceutical companies. We surveyed the requests from hospital pharmacists to research laboratories of pharmaceutical companies by questionnaire. The questionnaires were sent to 42 national university hospitals, and 129 replies were received from pharmacists of 28 hospitals. Highly placed requests regarding drug developments included commercialization of in-hospital preparations (15.5%), commercialization of dosage forms taken easily (13.2%), improvement of packaging of medical products (24.8%), the addition of doses (19.4%) and expansion of therapeutic use of narcotics (8.6%). Hospital pharmacists requested a wide variety of information regarding effectiveness, safety, drug interactions, contraindication, instruction for use, patient instruction and guidelines. In the response calculations, 91.5 percent of hospital pharmacists wished to take part in drug development, but 68.2% of hospital pharmacists did not have contact with the research and development departments of pharmaceutical companies. These results suggest that it is necessary to establish close and bilateral exchange between hospital pharmacists and research and development departments of pharmaceutical companies in order to realize unmet hospital pharmacist's requests.

Original languageEnglish
Pages (from-to)305-313
Number of pages9
JournalJapanese Journal of Clinical Pharmacology and Therapeutics
Volume36
Issue number6
DOIs
Publication statusPublished - 01-01-2005
Externally publishedYes

Fingerprint

Pharmacists
Research
Pharmaceutical Preparations
Hospital Restructuring
Pharmaceutical Research
Narcotics
Dosage Forms
Therapeutic Uses
Product Packaging
Drug Interactions
Guidelines
Safety

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{ca7454c534e144848e5fb986a5ab73f4,
title = "Requests from hospital pharmacists to research laboratories of pharmaceutical companies",
abstract = "It is likely that requests from hospital pharmacists to pharmaceutical companies are increasing with the greater sophistication and diversification of hospital pharmacist's practice in recent years. However, there is no nation-wide information concerning the requests to pharmaceutical companies. We surveyed the requests from hospital pharmacists to research laboratories of pharmaceutical companies by questionnaire. The questionnaires were sent to 42 national university hospitals, and 129 replies were received from pharmacists of 28 hospitals. Highly placed requests regarding drug developments included commercialization of in-hospital preparations (15.5{\%}), commercialization of dosage forms taken easily (13.2{\%}), improvement of packaging of medical products (24.8{\%}), the addition of doses (19.4{\%}) and expansion of therapeutic use of narcotics (8.6{\%}). Hospital pharmacists requested a wide variety of information regarding effectiveness, safety, drug interactions, contraindication, instruction for use, patient instruction and guidelines. In the response calculations, 91.5 percent of hospital pharmacists wished to take part in drug development, but 68.2{\%} of hospital pharmacists did not have contact with the research and development departments of pharmaceutical companies. These results suggest that it is necessary to establish close and bilateral exchange between hospital pharmacists and research and development departments of pharmaceutical companies in order to realize unmet hospital pharmacist's requests.",
author = "Masato Yamamoto and Toshitaka Nabeshima",
year = "2005",
month = "1",
day = "1",
doi = "10.3999/jscpt.36.6_305",
language = "English",
volume = "36",
pages = "305--313",
journal = "Japanese Journal of Clinical Pharmacology and Therapeutics",
issn = "0388-1601",
publisher = "Japanese Society of Clinical Pharmacology and Therapeutics",
number = "6",

}

Requests from hospital pharmacists to research laboratories of pharmaceutical companies. / Yamamoto, Masato; Nabeshima, Toshitaka.

In: Japanese Journal of Clinical Pharmacology and Therapeutics, Vol. 36, No. 6, 01.01.2005, p. 305-313.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Requests from hospital pharmacists to research laboratories of pharmaceutical companies

AU - Yamamoto, Masato

AU - Nabeshima, Toshitaka

PY - 2005/1/1

Y1 - 2005/1/1

N2 - It is likely that requests from hospital pharmacists to pharmaceutical companies are increasing with the greater sophistication and diversification of hospital pharmacist's practice in recent years. However, there is no nation-wide information concerning the requests to pharmaceutical companies. We surveyed the requests from hospital pharmacists to research laboratories of pharmaceutical companies by questionnaire. The questionnaires were sent to 42 national university hospitals, and 129 replies were received from pharmacists of 28 hospitals. Highly placed requests regarding drug developments included commercialization of in-hospital preparations (15.5%), commercialization of dosage forms taken easily (13.2%), improvement of packaging of medical products (24.8%), the addition of doses (19.4%) and expansion of therapeutic use of narcotics (8.6%). Hospital pharmacists requested a wide variety of information regarding effectiveness, safety, drug interactions, contraindication, instruction for use, patient instruction and guidelines. In the response calculations, 91.5 percent of hospital pharmacists wished to take part in drug development, but 68.2% of hospital pharmacists did not have contact with the research and development departments of pharmaceutical companies. These results suggest that it is necessary to establish close and bilateral exchange between hospital pharmacists and research and development departments of pharmaceutical companies in order to realize unmet hospital pharmacist's requests.

AB - It is likely that requests from hospital pharmacists to pharmaceutical companies are increasing with the greater sophistication and diversification of hospital pharmacist's practice in recent years. However, there is no nation-wide information concerning the requests to pharmaceutical companies. We surveyed the requests from hospital pharmacists to research laboratories of pharmaceutical companies by questionnaire. The questionnaires were sent to 42 national university hospitals, and 129 replies were received from pharmacists of 28 hospitals. Highly placed requests regarding drug developments included commercialization of in-hospital preparations (15.5%), commercialization of dosage forms taken easily (13.2%), improvement of packaging of medical products (24.8%), the addition of doses (19.4%) and expansion of therapeutic use of narcotics (8.6%). Hospital pharmacists requested a wide variety of information regarding effectiveness, safety, drug interactions, contraindication, instruction for use, patient instruction and guidelines. In the response calculations, 91.5 percent of hospital pharmacists wished to take part in drug development, but 68.2% of hospital pharmacists did not have contact with the research and development departments of pharmaceutical companies. These results suggest that it is necessary to establish close and bilateral exchange between hospital pharmacists and research and development departments of pharmaceutical companies in order to realize unmet hospital pharmacist's requests.

UR - http://www.scopus.com/inward/record.url?scp=30044452516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30044452516&partnerID=8YFLogxK

U2 - 10.3999/jscpt.36.6_305

DO - 10.3999/jscpt.36.6_305

M3 - Review article

VL - 36

SP - 305

EP - 313

JO - Japanese Journal of Clinical Pharmacology and Therapeutics

JF - Japanese Journal of Clinical Pharmacology and Therapeutics

SN - 0388-1601

IS - 6

ER -